Investor Update, page-65

Yes, my personal view is that we are looking at a long term partner within our diagnostics arm.

Should Anteo Energy prove to collaborators that technology works for their products ( see timeline in latest presentation, gives you a time period for when that can occur ), they will take us over, little doubt on that, we might retain 49% ownership for some time.
Exclusivity for one of them, for which they would be willing to pay an upfront fee to give them the competitive advantage.
The battery sector is way too competitive right now to allow long winded approval and testing regimes, the minute our technology proves viable for their products, they are in.

Anteo would keep the diagnostic division and would be able to finance a global roll out with partners for Anteobind.
Sona, Ellume, Chinese companies etc.

For those who wish to rake in the full benefits of Anteo Energy on potentially approved contracts with either MTA partners, this might simply be a bit unrealistic.
We are a cash strapped research company and a deal like that would be a major achievement, enabling us to move fully financed into Chinese and US partnerships on Anteobind, which were hinted at in the presentation.


all IMO